Kirk Randal J's Form 4 filing
Precigen, Inc. (PGEN) · filed Dec 22, 2025
- Accession no.
- 0001213900-25-124794
- Filed
- Dec 22, 2025
- Trade date
- Dec 22, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 11 non-derivative transactions. Open-market sales total $7.94M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kirk Randal JCIK 0001091823 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | Common Stock | SSaleDisposed | −555,119 | $4.18F1 | −$2,320,397.42 | 81,609,648 | Indirect | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −12,909 | $4.18F1 | −$53,959.62 | 477,492 | Indirect | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −94,341 | $4.18F1 | −$394,345.38 | 3,609,057 | Indirect | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −38,729 | $4.18F1 | −$161,887.22 | 1,615,634 | Indirect | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −12,909 | $4.18F1 | −$53,959.62 | 476,529 | Indirect | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −159,321 | $4.18F1 | −$665,961.78 | 3,785,116 | Indirect | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −42,702 | $4.18F1 | −$178,494.36 | 1,594,338 | Indirect | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −11,917 | $4.18F1 | −$49,813.06 | 566,162 | Indirect | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −9,931 | $4.18F1 | −$41,511.58 | 341,189 | Indirect | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −5,958 | $4.18F1 | −$24,904.44 | 447,773 | Indirect | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −956,200 | $4.18F1 | −$3,996,916 | 4,598,044 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.1800 to $4.1900, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Referenced by the price of 11 transactions in Table I.